Glioblastoma Multiforme Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 17
SKU : PH2127
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Glioblastoma Multiforme Market?
Glioblastoma Multiforme Market is expected to grow at a CAGR of 8.6% during the forecast period 2024-2031.
Who are the Key Players of Glioblastoma Multiforme Market ?
The key players operating in the global glioblastoma multiforme market are Genentech, Amgen, Merck & Co., Inc., Teva Pharmaceutical Industries, Ltd., Arbor Pharmaceuticals LLC., Sun Pharmaceutical Industries, Ltd., F. Hoffmann-Le Roche AG, Novartis, and Pfizer.
Related Reports
pharmaceuticals

Glioblastoma Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 23
Starting from

$4350

medical-devices

Multiparameter Patient Monitoring Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 30
Starting from

$4350

energy-and-power

Digital Multimeter Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 January 24
Starting from

$4350

clinical-diagnostics

Multiplexed Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 December 27
Starting from

$4350

medical-imaging

Multimodal Imaging Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 29
Starting from

$4350

medical-devices

Multimodal Biometric Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 17
Starting from

$4350